Recruiting

The BEAR Program for Women With Trauma Who Have Suicidal Thoughts

The current study aims to test the feasibility of a new form of group therapy for women who have a history of interpersonal trauma and current suicidal ideation. The Building Empowerment and Resilience (BEAR) Therapeutic group has been adapted for women who have experienced trauma and have current suicidal ideation. It incorporates psychological skills, psychoeducation about trauma and gender-based violence, and physical self-defense training, all within a therapeutic process. It will be implemented with women who…

ClinicalTrials.gov IDNCT07346638
PhaseNA
Enrollment30
SponsorStanford University
Age18 Years
SexFEMALE
I'm interested View official listing

Conditions studied

Interpersonal Trauma, Depression, PTSD, Anxiety, Suicidal Ideations, Sexual Assault

About this study

The current study aims to test the feasibility of a new form of group therapy for women who have a history of interpersonal trauma and current suicidal ideation. The Building Empowerment and Resilience (BEAR) Therapeutic group has been adapted for women who have experienced trauma and have current suicidal ideation. It incorporates psychological skills, psychoeducation about trauma and gender-based violence, and physical self-defense training, all within a therapeutic process. It will be implemented with women who have experienced interpersonal trauma (physical, sexual, or emotional abuse/neglect) and experience various mental health difficulties, including suicidal ideation. We aim to assess the feasibility to recruit and implement the BEAR group. Our ultimate aim is to assess whether the program can effect self-efficacy and suicidal ideation.

Interventions

Primary outcomes

Eligibility information

Inclusion Criteria: * Women ages 18-75 * History of physical, sexual, and/or sexual emotional violence, with subsequent interpersonal or psychological distress (e.g., depression or anxiety) related to this history. * Current suicidal thinking Exclusion Criteria: * Active, significant substance abuse, which could interfere with participation * Significant medical conditions that would preclude safe participation in the study * No history of interpersonal trauma * Acute psychiatric instability * History of assaultive behavior or is judged to be a potential risk to assault others. * No current suicidal ideation or behaviors * Unable to commit to the group for 12 weeks in-person

Study locations

Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.

Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-10-02.